Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
ROBERT HALF INTERNATIONAL, INC	RHI	Nyse +6 Other	1,298,230	71.48 USD	Stock
ROBERT HALF INTERNATIONAL, INC	RHJ	Deutsche Boerse AG	-	65.5 EUR
ROBERT HALF INTERNATIONAL, INC	0KX9	London S.E.	2	58.46 USD
ROBERT HALF INTERNATIONAL, INC	RHJ	Börse Stuttgart	-	65.5 EUR
ROBERT HALF INTERNATIONAL, INC	RHJ	BOERSE MUENCHEN	-	65.5 EUR
ROBERT HALF INC.	RHI *	Mexican S.E.	128	1,315 MXN
ROBERT HALF INTERNATIONAL, INC	RHJ	Berne S.E.	-	- CHF
ROBERT WALTERS PLC	RWA	London S.E. +3 Other	81,761	368.4 GBX	Stock
ROBERT WALTERS PLC	RWA	LIQUIDNET SYSTEMS	-	- GBX
ROBERT WALTERS PLC	RBW	Deutsche Boerse AG	-	4.04 EUR
ROBERT WALTERS PLC	RBW	Börse Stuttgart	-	4.12 EUR
RSE COLLECTION LLC - 1883 FIRST EDITION COPY OF TRE. ISLAND BY ROBERT STE. FUND, SERIES #TREASURE	COTRS	OTC Markets	-	2.5 USD	Stock
ROBERT HALF INC.	R1HI34	Sao Paulo	10	355.6 BRL	Stock
ROBERT B 2.9/MAY33		Börse Stuttgart	-	95.48 %	Bond
ROBERT B 2.9/MAY33		BOERSE MUENCHEN	-	96.18 %	Bond
ROBERT B 2.9/MAY33		Deutsche Boerse AG	-	95.74 %	Bond
FAKTOR OPTIONSSCHEIN - ROBERT HALF INT		Boerse Frankfurt Warrants	-	- EUR	Certificat
FAKTOR OPTIONSSCHEIN - ROBERT HALF INT		Börse Stuttgart	-	8.37 EUR	Certificat
FAKTOR OPTIONSSCHEIN - ROBERT HALF INT		Börse Stuttgart	-	2.98 EUR	Certificat

See all

News (1116)

PureTech Health : Proxy Form for 2024 AGM	04-25	PU
PureTech Health : Notice of Meeting for 2024 AGM	04-25	PU
PureTech Announces Annual Results for Year Ended December 31, 2023	04-25	BU
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1	04-23	AQ
China's drugmakers can't sell mRNA shots but haven't quit yet	04-19	RE
Ceragon : NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K	04-18	PU
Moderna : 2024 Proxy Statement	04-16	PU
Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health's Advisory Board	01-26	AQ
Daré Bioscience’s DARE-LARC1 Platform Technology Achieves Proof-of-Concept Device that has Transformative Potential for Women’s Health as well as in Treating a Broad Range of Diseases	01-04	AQ
Transcript : Mineral Resources Limited - Shareholder/Analyst Call	11-16
Transcript : Alexandria Real Estate Equities, Inc., Q3 2023 Earnings Call, Oct 24, 2023	24/10/23
MinRes Annual Reporting Suite: Legacy of Leadership	16/10/23	PU
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1	21/09/23	AQ
Théâtre l'Étoile Becomes Théâtre Manuvie	18/09/23	AQ
HERVOLUTION Therapeutics appoints Moderna Co-Founder and MIT Professor Robert S. Langer as Chair of its Scientific Advisory Board	14/09/23	AQ
Ipsen : and Exicure enter into exclusive collaboration targeting rare neurodegenerative disorders	30/08/23	PU
PureTech Health plc – Half-Year Report	29/08/23	BU
Daré Bioscience Announces Publication in The Journal of The North American Menopause Society of Positive Efficacy Findings for the Treatment of Menopausal Symptoms from a Phase 1/2 Clinical Trial of DARE-HRT1 Intravaginal Rings	09/08/23	AQ
Daré Bioscience to Present at the 9th Annual International Symposium of Drug Delivery Systems	11/07/23	AQ
Sigilon Therapeutics : Lilly to Acquire Sigilon Therapeutics - Form 8-K	29/06/23	PU
Lilly to Acquire Sigilon Therapeutics	29/06/23	PR
Dr. Jeremy Caplin Joins PetVivo Holdings, Inc. as the Director of Research	27/06/23	AQ
Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1/2 Open-Label Safety and Pharmacokinetics Study of DARE-HRT1 in Healthy Postmenopausal Women	21/06/23	AQ
DarÃ© Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1/2 Open-Label Safety and Pharmacokinetics Study of DARE-HRT1 in Healthy Postmenopausal Women	21/06/23	CI
An affiliate of Blackstone Infrastructure Partners, L.P., a fund managed by Blackstone Inc. (NYSE:BX), entered into a definitive agreement to acquire a 19.9% equity interest in Northern Indiana Public Service Company, LLC from NiSource Inc. (NYSE:NI) for $2.2 billion.	19/06/23	CI
Results of PureTech's Annual General Meeting	13/06/23	BU
Quebec firm to pay $10M to avoid charges over bribes promised to Philippine officials	31/05/23	AQ
Sigilon Announces Reverse Stock Split of Common Stock	22/05/23	AQ
SIGILON THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	09/05/23	AQ
Sigilon Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights	09/05/23	GL
PureTech Health : Notice of Meeting for 2023 AGM	28/04/23	PU
PureTech Health : Proxy Form for 2023 AGM	28/04/23	PU
PureTech Announces Annual Results for Year Ended December 31, 2022	28/04/23	BU
Daré Bioscience Announces Publication of Positive Safety and Acceptability Data from Phase 1 Clinical Trial that Support the Potential of DARE-HRT1 Intravaginal Ring as a New Menopausal Hormone Therapy	18/04/23	AQ
Sigilon Therapeutics to Present at the Needham Virtual Healthcare Conference	18/04/23	AQ
Sigilon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights	14/03/23	AQ
InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury	09/03/23	BU
Domtar Corporation completed the acquisition of Resolute Forest Products Inc. from Fairfax Financial Holdings Limited, Chou Associates Management Inc., Dimensional Fund Advisors LP and others.	28/02/23	CI
FREQUENCY THERAPEUTICS, INC. : Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	13/02/23	AQ
Frequency Therapeutics, Inc. Appoints Christopher Loose, Ph.D., as Interim Chief Executive Officer	13/02/23	CI
Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that Support the Potential of DARE-HRT1 as an Effective Hormone Therapy for both Vasomotor and Vaginal Symptoms of Menopause	26/01/23	AQ
Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that Support the Potential of DARE-HRT1 as an Effective Hormone Therapy for both Vasomotor and Vaginal Symptoms of Menopause	26/01/23	CI
Transcript : Establishment Labs Holdings Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-12-2023 07:30 AM	12/01/23
Daré Bioscience Announces Positive Pharmacokinetic (PK) Results from the DARE-HRT1 Phase 1 / 2 Study that Support the Potential of DARE-HRT1 as an Effective Hormone Therapy for both Vasomotor and Vaginal Symptoms of Menopause	09/01/23	AQ
Daré Bioscience, Inc. Announces Positive Pharmacokinetic Results from the DARE-HRT1 Phase 1 / 2 Study	09/01/23	CI

1234NextSee all

Companies (31)

CONSTELLATION BRANDS, INC. 46 724 M $

Constellation Brands, Inc. is one of the leading American producers of wines, spirits and beers. Net sales (before intra-group eliminations) break down by family of products as follows: - beer (76.2%): Corona Extra, Corona Light, Modelo Especial, Modelo ...

CONSTELLATION BRANDS, INC. 46 724 M $

MICHELIN (CGDE) 28 653 M $

Compagnie Générale des Etablissements Michelin is one of the world leaders in manufacturing and marketing of tires. The products are mainly sold under the Michelin, BFGoodrich, Kleber, Uniroyal and Taurus brands. Net sales break down by activity as follow ...

MICHELIN (CGDE) 28 653 M $

ROBERT HALF INTERNATIONAL, INC 7 375 M $

Robert Half International, Inc. is the world leader of specialized recruitment. The group operates essentially in the financial and accounting, bank and insurance, legal and tax sectors. Net sales break down as follows: - staff temporary investment (62.6 ...

PC GROUP, INC. 1 062 $

Personal Care Group, Inc., formerly PC Group, Inc, designs, develops and manufactures custom-made, prescription orthotic devices for medical practitioners and, specifically, podiatrists. The Company makes biomechanical products for those with walking diff ...

NEO ENERGY METALS PLC 11 M $

Neo Energy Metals PLC, formerly Stranger Holdings Plc, is a United Kingdom-based mining and development company focused solely on uranium and strategic metals supply. The Company has a 70% interest in the Henkries Uranium Project, which is located in the ...

BOSCH FREN SISTEMLERI SANAYI VE TICARET 954 M $

Bosch Fren Sistemleri Sanayi ve Ticaret AS is a Turkey-based automotive parts manufacturer. It is primarily engaged in the production, sale and distribution of hydraulic brakes for commercial vehicles and light-weight trucks, as well as various allied pro ...

LEOPARD LAKE GOLD CORP. 470 777 $

Leopard Lake Gold Corp. is engaged in the business of mineral exploration and the acquisition of mineral property assets in Canada. The Companyâs properties include St. Robert property, which is made up of about 220 claims, totaling 11,000 hectares (ha) ...

1234Next

Insiders

Robert Langer

Robert S. Langer

Robert S.
Langer was the founder of Teal Bio, Inc. and held the title of Director.

Robert Langer

Robert Langer is the founder of TransForm Pharmaceuticals, Inc. where he holds the title of Director starting in 1999.

Robert R. Langer

Robert R.
Langer is currently the Chief Operating Officer at Universal International, Inc. since 1998 and at Only Deals, Inc. since 1992.
He was formerly the Chief Operating Officer at Odds N Ends, Inc.

Robert A. Langer

Robert Langer

Robert Langer is the founder of Mepsgen Co. Ltd.
and currently holds the title of Strategic Advisor.

Robert Langer

Robert S. Langer

No results for this search